Cargando…
An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
BACKGROUND: Elevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patients from the Atherosclerosis Risk in Communities Stu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533018/ https://www.ncbi.nlm.nih.gov/pubmed/28341776 http://dx.doi.org/10.1161/JAHA.116.005257 |
_version_ | 1783253564158640128 |
---|---|
author | Seidelmann, Sara B. Vardeny, Orly Claggett, Brian Yu, Bing Shah, Amil M. Ballantyne, Christie M. Selvin, Elizabeth MacRae, Calum A. Boerwinkle, Eric Solomon, Scott D. |
author_facet | Seidelmann, Sara B. Vardeny, Orly Claggett, Brian Yu, Bing Shah, Amil M. Ballantyne, Christie M. Selvin, Elizabeth MacRae, Calum A. Boerwinkle, Eric Solomon, Scott D. |
author_sort | Seidelmann, Sara B. |
collection | PubMed |
description | BACKGROUND: Elevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patients from the Atherosclerosis Risk in Communities Study to investigate associations with N‐terminal pro‐BNP (NT‐proBNP) levels and outcomes. METHODS AND RESULTS: A total of 11 361 black and white patients with rs198389 genotyping attended visit 1 (aged 45–64 years; 1987–1989), with follow‐up visits occurring every 3 years (visit 2–visit 4, 1990–1999), followed by visit 5 (2011–2013). NT‐proBNP levels were measured at visits 2, 4, and 5. At visit 2, the GG genotype (frequency 18%) was associated with a 41% higher mean plasma level of NT‐proBNP compared with the AA genotype (frequency 34%), with intermediate values observed in AGs (P=4.2×10(−52)). The GG genotype was associated with reduced systolic blood pressure (−1.6 mm Hg, P=0.006), diastolic blood pressure (−1 mm Hg, P=0.003), antihypertension medication use (odds ratio, 0.85; 95% CI, 0.74–0.97 [P=0.02]), and hypertension (odds ratio, 0.81; 95% CI, 0.72–0.92 [P=0.002]) compared with the AA genotype with intermediate values in AGs. These relationships persisted throughout subsequent visits. After a median follow‐up of 23 years, there were 4031 deaths. With and without covariate adjustment, the GG genotype was associated with modestly lower mortality (hazard ratio, 0.86; 95% CI, 0.78–0.95), primarily reflective of cardiovascular death (hazard ratio, 0.75; 95% CI, 0.61–0.92), and increased residual lifespan of 8 months from 50 years of age (P=0.02) versus AAs. CONCLUSIONS: The rs198389 G allele in the NPPB promoter is associated with elevated levels of NT‐proBNP throughout adult life, reduced blood pressure, hypertension and cardiovascular mortality, and increased lifespan. |
format | Online Article Text |
id | pubmed-5533018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55330182017-08-14 An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality Seidelmann, Sara B. Vardeny, Orly Claggett, Brian Yu, Bing Shah, Amil M. Ballantyne, Christie M. Selvin, Elizabeth MacRae, Calum A. Boerwinkle, Eric Solomon, Scott D. J Am Heart Assoc Original Research BACKGROUND: Elevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patients from the Atherosclerosis Risk in Communities Study to investigate associations with N‐terminal pro‐BNP (NT‐proBNP) levels and outcomes. METHODS AND RESULTS: A total of 11 361 black and white patients with rs198389 genotyping attended visit 1 (aged 45–64 years; 1987–1989), with follow‐up visits occurring every 3 years (visit 2–visit 4, 1990–1999), followed by visit 5 (2011–2013). NT‐proBNP levels were measured at visits 2, 4, and 5. At visit 2, the GG genotype (frequency 18%) was associated with a 41% higher mean plasma level of NT‐proBNP compared with the AA genotype (frequency 34%), with intermediate values observed in AGs (P=4.2×10(−52)). The GG genotype was associated with reduced systolic blood pressure (−1.6 mm Hg, P=0.006), diastolic blood pressure (−1 mm Hg, P=0.003), antihypertension medication use (odds ratio, 0.85; 95% CI, 0.74–0.97 [P=0.02]), and hypertension (odds ratio, 0.81; 95% CI, 0.72–0.92 [P=0.002]) compared with the AA genotype with intermediate values in AGs. These relationships persisted throughout subsequent visits. After a median follow‐up of 23 years, there were 4031 deaths. With and without covariate adjustment, the GG genotype was associated with modestly lower mortality (hazard ratio, 0.86; 95% CI, 0.78–0.95), primarily reflective of cardiovascular death (hazard ratio, 0.75; 95% CI, 0.61–0.92), and increased residual lifespan of 8 months from 50 years of age (P=0.02) versus AAs. CONCLUSIONS: The rs198389 G allele in the NPPB promoter is associated with elevated levels of NT‐proBNP throughout adult life, reduced blood pressure, hypertension and cardiovascular mortality, and increased lifespan. John Wiley and Sons Inc. 2017-03-24 /pmc/articles/PMC5533018/ /pubmed/28341776 http://dx.doi.org/10.1161/JAHA.116.005257 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Seidelmann, Sara B. Vardeny, Orly Claggett, Brian Yu, Bing Shah, Amil M. Ballantyne, Christie M. Selvin, Elizabeth MacRae, Calum A. Boerwinkle, Eric Solomon, Scott D. An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
title | An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
title_full | An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
title_fullStr | An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
title_full_unstemmed | An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
title_short | An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
title_sort | nppb promoter polymorphism associated with elevated n‐terminal pro–b‐type natriuretic peptide and lower blood pressure, hypertension, and mortality |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533018/ https://www.ncbi.nlm.nih.gov/pubmed/28341776 http://dx.doi.org/10.1161/JAHA.116.005257 |
work_keys_str_mv | AT seidelmannsarab annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT vardenyorly annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT claggettbrian annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT yubing annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT shahamilm annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT ballantynechristiem annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT selvinelizabeth annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT macraecaluma annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT boerwinkleeric annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT solomonscottd annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT seidelmannsarab nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT vardenyorly nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT claggettbrian nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT yubing nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT shahamilm nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT ballantynechristiem nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT selvinelizabeth nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT macraecaluma nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT boerwinkleeric nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality AT solomonscottd nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality |